Aftervisit
A consent-based post-visit navigation service for health-system quality teams that turns an authorized visit plan into source-linked plain language and patient-approved tasks, coordinates referrals through supported channels, and tracks outreach, scheduling, attendance, results, clinician review, and loop closure as separate evidence.
Patients can leave a visit with diagnoses, medication instructions, tests, referrals, warning signs, and follow-up tasks spread across summaries, portals, calls, and scheduling systems. Aftervisit helps the patient understand the clinician-authored plan and choose what assistance to receive. It does not listen, ingest, contact, or book by implication. A generated explanation is not medical advice, a referral order is not an appointment, an appointment is not attendance, attendance is not result review, and a closed administrative loop is not clinical success or reimbursement. Consent, source note, clinician-authored instruction, plain-language candidate, patient confirmation, referral order, network observation, authorization, booking request, provider acknowledgment, attendance, result, clinician review, patient outcome, opt-out, correction, and emergency escalation remain distinct.
A health-system quality, population-health, ambulatory operations, care-management, patient-experience, or access leader responsible for post-visit follow-through and patient support.
The recent launch and sustained navigation spending validate current demand rather than a hard deadline.
Plain-language drafts, task extraction, outreach, and routing can scale, while clinical review and scheduling exceptions add labor.
Three cross-references and five inbound connections show meaningful adjacency with no direct connections.
Three cross-references, five inbound links, a confirmed consent-based post-visit navigation launch, a specific health-system quality buyer, and a differentiated buyer channel support a real post-visit coordination opportunity.
There are no direct connections, stage one verified no integration capability, a close product already provides summary and referral navigation, clinical and privacy risk is high, health-system interfaces and payer data are fragmented, loop closure is not a universal quality or reimbursement metric, and no structural incumbent cost is evidenced.
Discussion
No comments yet — be the first to weigh in.